Sodium-glucose cotransporter 2 (SGLT-2): Cause of prolonged euglycaemic ketoacidosis and ketonaemia following general anaesthesia?

被引：0
|
作者：
Chong, Z. M. [1 ]
Stirling, A. [1 ]
Sandeep, T. [1 ]
机构：
[1] Monklands Hosp, Diabet & Endocrinol, Airdrie, Lanark, Scotland
来源：
DIABETIC MEDICINE | 2018年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P205
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [41] SGLT-2 inhibitor associated euglycaemic diabetic ketoacidosis in an orthopaedic trauma patient
    Ritchie, Duncan Taylor
    Dixon, James
    BMJ CASE REPORTS, 2022, 15 (09)
  • [42] Diabetes Leads to Sodium-Glucose Cotransporter 2 (SGLT2) Increase in the Retina
    Leley, Sameer P.
    Luo, Qianyi
    Alex, Alpha L.
    Bhatwadekar, Ashay D.
    DIABETES, 2019, 68
  • [43] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Benefits Versus Risk
    Jasleen, Bains
    Vishal, Gupta K.
    Sameera, Malepati
    Fahad, Molla
    Brendan, O'Brien
    Deion, Santander
    Pemminati, Sudhakar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [44] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Harms or Unexpected Benefits?
    Andreea, Munteanu Madalina
    Surabhi, Swarnkar
    Razvan-Ionut, Popescu
    Lucia, Ciobotaru
    Camelia, Nicolae
    Emil, Tufanoiu
    Tiberiu, Nanea Ioan
    MEDICINA-LITHUANIA, 2023, 59 (04):
  • [45] Sodium-glucose cotransporter 2 inhibitors (SGLT2i): renal implications
    Alejandrina M. Castañeda
    Amanda Dutra-Rufato
    Maria J. Juarez
    Luis Grosembacher
    Henry Gonzalez-Torres
    Carlos G. Musso
    International Urology and Nephrology, 2021, 53 : 291 - 299
  • [46] Sodium-glucose cotransporter 2 inhibitors (SGLT2i): renal implications
    Castaneda, Alejandrina M.
    Dutra-Rufato, Amanda
    Juarez, Maria J.
    Grosembacher, Luis
    Gonzalez-Torres, Henry
    Musso, Carlos G.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (02) : 291 - 299
  • [47] Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes
    Abdul-Ghani, Muhammad A.
    Norton, Luke
    DeFronzo, Ralph A.
    ENDOCRINE REVIEWS, 2011, 32 (04) : 515 - 531
  • [48] Comparative safety of sodium-glucose cotransporter-2 (SGLT-2) inhibitors: Risk of hospitalization and cardiovascular events in patients with type 2 diabetes
    Mansour, Omar
    Chang, Hsien-Yen
    Alexander, G. Caleb
    Singh, Sonal
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 52 - 52
  • [49] Euglycemic diabetic ketoacidosis induced by sodium-glucose cotransporter 2 inhibitor in the setting of prolonged fasting: a case report
    Alkatheeri, Abrar
    Alseddeeqi, Eiman
    JOURNAL OF MEDICAL CASE REPORTS, 2022, 16 (01)
  • [50] Sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs: Assessment of safety in fasting diabetics
    Khan, M. I. H.
    Azhar, U.
    Javaid, A.
    Khan, F. I.
    Shakeel, S.
    Sagheer, A.
    DIABETIC MEDICINE, 2020, 37 : 128 - 128
12345